3 ms·
The problem is RM as you know, is the negative effects from immunosuppression. Makes it tougher to justify than others.
by the__alchemist 1y ago
The problem is RM as you know, is the negative effects from immunosuppression. Makes it tougher to justify than others.
- robwwilliams 1y agoYes, at higher doses that affect mTORC2 signaling. At a low intermittent dose it is an immune modulator, not an immune suppressor. Much work on parsing the two. But we do not know much about the role of genetic difference in responses ti this drug, so caution is appropriate.